Programmed cell death-1/Programmed cell death ligand-1(PD-1/PD-L1) inhibitors, heralding a new era of immunotherapy in the management of advanced Non-Small Cell Lung Cancer (NSCLC)
2017 ◽
Vol 12
◽
pp. 6-13
◽
Keyword(s):
New Era
◽
2019 ◽
Vol 58
(21)
◽
pp. 3129-3132
◽
Keyword(s):
Keyword(s):
Keyword(s):